Collecting Duct Carcinoma Survival Rate

The prognosis is poor and most patients develop metastases or die 120 121 136 137 within 2 years of presentation.

Collecting duct carcinoma survival rate.

Collecting duct carcinoma cdc is a rare aggressive form of renal carcinoma that presents at an advanced stage and has a poor prognosis. Little is known concerning the optimal management of cdc. Collecting duct carcinomas are rare aggressive malignancies with poor prognosis arising from collecting duct epithelium of the kidney accounting for about 1 3 of all renal cell carcinoma rcc. Collecting duct carcinoma cdc is a rare and aggressive form of kidney cancer that begins in the collecting duct of the kidney.

This aggressive malignancy is considered to be derived from the collecting duct of the kidney and has a poor prognosis in the majority of patients 2 5 with a median survival time of only 22 months following nephrectomy 6. Many people with cdc have no signs or symptoms until the cancer is at an advanced stage. Histochemical and immunohistochemical studies are often necessary for the diagnosis of collecting duct carcinoma. 1 these tumours are found to be locally advanced and with distant metastasis at presentation with 1 to 3 years disease specific survival.

We present the results of a systematic review addressing the management of cdc and the mcmaster university cdc series.